You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020241043
Dec 20205409
Jan 20212002
Feb 20217806
Mar 202186012
Apr 202110609
May 20215606
Jun 20210014
Jul 20210016
Aug 20210016
Sep 2021004
Oct 202144027
Nov 2021128029
Dec 20215404
Jan 20225002
Feb 202211606
Mar 202210409
Apr 202210007
May 20228203
Jun 20226607
Jul 20225403
Aug 2022110014
Sep 20226604
Oct 20227401
Nov 20226609
Dec 2022113010
Jan 202374010
Feb 20237005
Mar 202378010
Apr 20234606
May 20235405
Jun 20235203
Jul 202392010
Aug 20237609
Sep 20234805
Oct 202398013
Nov 20236207
Dec 20237205
Jan 20242402
Feb 20243403
Mar 202462016
Apr 202482012
May 20244201
Jun 20244402
Jul 20246202
Aug 20244805
Sep 20245803
Oct 202466011
Nov 202458016
Dec 20245609
Jan 202534022
Feb 202524011
Mar 20250015
Apr 20250010
May 2025005
Jun 2025006
Total33840511